Advancing human pulmonary disease models in preclinical research: opportunities for .
作者信息
Artzy-Schnirman Arbel, Lehr Claus-Michael, Sznitman Josué
机构信息
Department of Biomedical Engineering, Technion - Israel Institute of Technology, Haifa, Israel.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Saarland University, Saarbrücken, Germany.
出版信息
Expert Opin Drug Deliv. 2020 May;17(5):621-625. doi: 10.1080/17425247.2020.1738380. Epub 2020 Mar 11.
Abstract
摘要
相似文献
1
Advancing human pulmonary disease models in preclinical research: opportunities for .推进临床前研究中的人类肺部疾病模型：机遇
Expert Opin Drug Deliv. 2020 May;17(5):621-625. doi: 10.1080/17425247.2020.1738380. Epub 2020 Mar 11.
2
[Advances of using microfluidic chips for research and diagnosis of pulmonary inflammatory diseases].[微流控芯片在肺部炎症性疾病研究与诊断中的应用进展]
Sheng Wu Gong Cheng Xue Bao. 2021 Nov 25;37(11):3905-3914. doi: 10.13345/j.cjb.210025.
3
Organs-on-chips technologies - A guide from disease models to opportunities for drug development.器官芯片技术——从疾病模型到药物开发机遇的指南。
Biosens Bioelectron. 2023 Jul 1;231:115271. doi: 10.1016/j.bios.2023.115271. Epub 2023 Mar 31.
4
Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.在肺血管的临床前人体相关模型芯片上的进展。
Eur J Pharm Sci. 2024 Apr 1;195:106709. doi: 10.1016/j.ejps.2024.106709. Epub 2024 Jan 19.
5
Human Multi-Compartment Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini.用于模拟呼吸道空气传播的人体多腔室平台：从鼻腔到肺腺泡
Front Physiol. 2022 Mar 8;13:853317. doi: 10.3389/fphys.2022.853317. eCollection 2022.
6
Engineering organoids-on-chips for drug testing and evaluation.用于药物测试和评估的芯片类器官工程
Metabolism. 2025 Jan;162:156065. doi: 10.1016/j.metabol.2024.156065. Epub 2024 Nov 9.
7
Microfluidic Technologies in Advancing Cancer Research.推进癌症研究的微流控技术
Micromachines (Basel). 2024 Nov 28;15(12):1444. doi: 10.3390/mi15121444.
8
Stem cell-based Lung-on-Chips: The best of both worlds?基于干细胞的肺芯片：两全其美？
Adv Drug Deliv Rev. 2019 Feb 1;140:12-32. doi: 10.1016/j.addr.2018.07.005. Epub 2018 Jul 25.
9
Lung-on-a-chip: the future of respiratory disease models and pharmacological studies.肺芯片：呼吸疾病模型和药理学研究的未来。
Crit Rev Biotechnol. 2020 Mar;40(2):213-230. doi: 10.1080/07388551.2019.1710458. Epub 2020 Jan 6.
10
Tissue Chips in Space: Modeling Human Diseases in Microgravity.太空组织芯片：在微重力下模拟人类疾病。
Pharm Res. 2019 Dec 17;37(1):8. doi: 10.1007/s11095-019-2742-0.
引用本文的文献
1
Advanced models for respiratory disease and drug studies.呼吸系统疾病和药物研究的先进模型。
Med Res Rev. 2023 Sep;43(5):1470-1503. doi: 10.1002/med.21956. Epub 2023 Apr 29.
2
A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections.一株具有显著屏障功能的人肺泡上皮细胞系（“Arlo”），可用于研究药物通透性和病毒感染。
Adv Sci (Weinh). 2023 Mar;10(8):e2207301. doi: 10.1002/advs.202207301. Epub 2023 Feb 7.
3
Ventilation-induced epithelial injury drives biological onset of lung trauma in vitro and is mitigated with prophylactic anti-inflammatory therapeutics.通气诱导的上皮损伤在体外驱动肺损伤的生物学起始，并可通过预防性抗炎治疗减轻。
Bioeng Transl Med. 2021 Dec 1;7(2):e10271. doi: 10.1002/btm2.10271. eCollection 2022 May.
4
Human Multi-Compartment Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini.用于模拟呼吸道空气传播的人体多腔室平台：从鼻腔到肺腺泡
Front Physiol. 2022 Mar 8;13:853317. doi: 10.3389/fphys.2022.853317. eCollection 2022.
5
Investigation of the role of the autophagic protein LC3B in the regulation of human airway epithelium cell differentiation in COPD using a biomimetic model.使用仿生模型研究自噬蛋白LC3B在慢性阻塞性肺疾病（COPD）中对人气道上皮细胞分化调节的作用。
Mater Today Bio. 2021 Dec 8;13:100182. doi: 10.1016/j.mtbio.2021.100182. eCollection 2022 Jan.
6
PerfuPul-A Versatile Perfusable Platform to Assess Permeability and Barrier Function of Air Exposed Pulmonary Epithelia.PerfuPul-A：一个用于评估暴露于空气中的肺上皮细胞通透性和屏障功能的多功能可灌注平台
Front Bioeng Biotechnol. 2021 Oct 6;9:743236. doi: 10.3389/fbioe.2021.743236. eCollection 2021.
7
Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.用于呼吸治疗的先进的具有人类相关性的体外肺平台。
Adv Drug Deliv Rev. 2021 Sep;176:113901. doi: 10.1016/j.addr.2021.113901. Epub 2021 Jul 29.
8
A Bioinspired Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface Conditions.一种用于研究纳米/微粒在循环拉伸和气液界面条件下的颗粒动力学的仿生肺模型。
Front Bioeng Biotechnol. 2021 Jan 29;9:616830. doi: 10.3389/fbioe.2021.616830. eCollection 2021.
9
An Inflamed Human Alveolar Model for Testing the Efficiency of Anti-inflammatory Drugs .用于测试抗炎药物疗效的炎症性人肺泡模型
Front Bioeng Biotechnol. 2020 Aug 21;8:987. doi: 10.3389/fbioe.2020.00987. eCollection 2020.
本文引用的文献
1
Capturing the Onset of Bacterial Pulmonary Infection in Acini-On-Chips.在腺泡芯片中捕捉细菌性肺部感染的起始阶段。
Adv Biosyst. 2019 Sep;3(9):e1900026. doi: 10.1002/adbi.201900026. Epub 2019 Jul 31.
2
3
Like Aerosol Inhalation Exposure for Cytotoxicity Assessment Using Platforms.如使用平台进行细胞毒性评估的气溶胶吸入暴露。
Front Bioeng Biotechnol. 2020 Feb 20;8:91. doi: 10.3389/fbioe.2020.00091. eCollection 2020.
4
Microphysiological systems modeling acute respiratory distress syndrome that capture mechanical force-induced injury-inflammation-repair.微生理系统对急性呼吸窘迫综合征进行建模，该模型能够捕捉机械力诱导的损伤-炎症-修复过程。
APL Bioeng. 2019 Nov 22;3(4):041503. doi: 10.1063/1.5111549. eCollection 2019 Dec.
5
Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline.用于吸入测定的体外肺芯片平台的最新进展：从前景到研发管线。
Eur J Pharm Biopharm. 2019 Nov;144:11-17. doi: 10.1016/j.ejpb.2019.09.006. Epub 2019 Sep 6.
6
Challenges and strategies in drug delivery systems for treatment of pulmonary infections.肺部感染治疗中药物传递系统的挑战与策略。
Eur J Pharm Biopharm. 2019 Nov;144:110-124. doi: 10.1016/j.ejpb.2019.09.002. Epub 2019 Sep 4.
7
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.微生理肺模型评估新型药物模式的安全性：从生物制药角度来看。
Lab Chip. 2019 Sep 27;19(19):3152-3161. doi: 10.1039/c9lc00492k.
8
Through the Looking Glass: Models for Inhalation Toxicology and Interindividual Variability in the Airway.透过镜子：吸入毒理学模型与气道个体间差异
Appl In Vitro Toxicol. 2018 Jun 1;4(2):115-128. doi: 10.1089/aivt.2018.0002.
9
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.推进新型结核病治疗方案的研发：转化医学与临床药理学及微生物学的重要作用。
PLoS Med. 2019 Jul 5;16(7):e1002842. doi: 10.1371/journal.pmed.1002842. eCollection 2019 Jul.
10
The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement.《全球肺部疾病负担：最普遍的问题和改进机会》。
Ann Glob Health. 2019 Jan 22;85(1):1. doi: 10.5334/aogh.2411.
Zotero 插件